The longevity shift: strategic implications of the longevity medicine revolution - Ipsos
The longevity shift: strategic implications of the longevity medicine revolution - Ipsos

The longevity shift: strategic implications of the longevity medicine revolution

Turn longevity from trend to strategy: where should pharma play - and how to win?

Longevity is emerging as one of the most dynamic frontiers in healthcare innovation. In 2025, longevity’s not just about living longer; it’s about preserving vitality, function and independence - creating new strategic options for portfolios and go to market.

This new point of view maps the emergence of longevity medicine, the strategic implications and the growing recognition that longevity may become a defining theme in the future of medicine.
 

The author(s)

More insights about Health

Related news

  • KEYS: Our World in Motion
    E mobility Events replay

    [Webinar] KEYS: Our World in Motion

    At our next KEYS webinar, we’ll be launching the inaugural Ipsos Mobility Report.
  • [Webinar] Real evidence from real experiences: Patient Centric Evidence
    Healthcare Webinar

    [Webinar] Real evidence from real experiences: Patient Centric Evidence

    Regulators, payers and clinicians are asking for more than traditional real world evidence (RWE). They want to understand how treatments affect people’s daily lives - not just what is written in the case report form. But how can you build patient-centric evidence that stands up to scientific, regulatory and commercial scrutiny?
  • Battle For Attention - KEYS Webinar from Ipsos
    Communications Events replay

    [Webinar] KEYS: Battle For Attention

    In today’s hyper-fragmented landscape, communicating using short-form content and social media platforms is an essential part of our toolkit. But are they better suited to short-term engagement rather than long-term brand building? And what does genuinely innovative and creative advertising look like these days?